438 related articles for article (PubMed ID: 20513137)
21. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions.
Mußotter T; Kluwe L; Högel J; Nguyen R; Cooper DN; Mautner VF; Kehrer-Sawatzki H
BMC Med Genet; 2012 Oct; 13():98. PubMed ID: 23101500
[TBL] [Abstract][Full Text] [Related]
22. Emerging genotype-phenotype relationships in patients with large NF1 deletions.
Kehrer-Sawatzki H; Mautner VF; Cooper DN
Hum Genet; 2017 Apr; 136(4):349-376. PubMed ID: 28213670
[TBL] [Abstract][Full Text] [Related]
23. Mutation spectrum of NF1 and clinical characteristics in 78 Korean patients with neurofibromatosis type 1.
Ko JM; Sohn YB; Jeong SY; Kim HJ; Messiaen LM
Pediatr Neurol; 2013 Jun; 48(6):447-53. PubMed ID: 23668869
[TBL] [Abstract][Full Text] [Related]
24. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
[TBL] [Abstract][Full Text] [Related]
25. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Boudry-Labis E; Roche-Lestienne C; Nibourel O; Boissel N; Terre C; Perot C; Eclache V; Gachard N; Tigaud I; Plessis G; Cuccuini W; Geffroy S; Villenet C; Figeac M; Leprêtre F; Renneville A; Cheok M; Soulier J; Dombret H; Preudhomme C;
Am J Hematol; 2013 Apr; 88(4):306-11. PubMed ID: 23460398
[TBL] [Abstract][Full Text] [Related]
26. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
[TBL] [Abstract][Full Text] [Related]
27. Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.
Kehrer-Sawatzki H; Cooper DN
Hum Genet; 2021 Dec; 140(12):1635-1649. PubMed ID: 34535841
[TBL] [Abstract][Full Text] [Related]
28. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis type 1: from genotype to phenotype.
Pasmant E; Vidaud M; Vidaud D; Wolkenstein P
J Med Genet; 2012 Aug; 49(8):483-9. PubMed ID: 22889851
[TBL] [Abstract][Full Text] [Related]
30. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH.
Shen MH; Mantripragada K; Dumanski JP; Frayling I; Upadhyaya M
Clin Genet; 2007 Sep; 72(3):238-44. PubMed ID: 17718862
[TBL] [Abstract][Full Text] [Related]
31. Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse.
Jenne DE; Tinschert S; Dorschner MO; Hameister H; Stephens K; Kehrer-Sawatzki H
Genes Chromosomes Cancer; 2003 Jun; 37(2):111-20. PubMed ID: 12696059
[TBL] [Abstract][Full Text] [Related]
32. A mild neurofibromatosis type 1 phenotype produced by the combination of the benign nature of a leaky NF1-splice mutation and the presence of a complex mosaicism.
Fernández-Rodríguez J; Castellsagué J; Benito L; Benavente Y; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2011 Jul; 32(7):705-9. PubMed ID: 21394830
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis: novel and recurrent mutations in Turkish patients.
Terzi YK; Oguzkan S; Anlar B; Aysun S; Ayter S
Pediatr Neurol; 2007 Dec; 37(6):421-5. PubMed ID: 18021924
[TBL] [Abstract][Full Text] [Related]
34. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands.
van Minkelen R; van Bever Y; Kromosoeto JN; Withagen-Hermans CJ; Nieuwlaat A; Halley DJ; van den Ouweland AM
Clin Genet; 2014 Apr; 85(4):318-27. PubMed ID: 23656349
[TBL] [Abstract][Full Text] [Related]
35. Growth in neurofibromatosis 1 microdeletion patients.
Ning X; Farschtschi S; Jones A; Kehrer-Sawatzki H; Mautner VF; Friedman JM
Clin Genet; 2016 Mar; 89(3):351-4. PubMed ID: 26111455
[TBL] [Abstract][Full Text] [Related]
36. Antisense therapeutics for neurofibromatosis type 1 caused by deep intronic mutations.
Pros E; Fernández-Rodríguez J; Canet B; Benito L; Sánchez A; Benavides A; Ramos FJ; López-Ariztegui MA; Capellá G; Blanco I; Serra E; Lázaro C
Hum Mutat; 2009 Mar; 30(3):454-62. PubMed ID: 19241459
[TBL] [Abstract][Full Text] [Related]
37. Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).
Messiaen L; Vogt J; Bengesser K; Fu C; Mikhail F; Serra E; Garcia-Linares C; Cooper DN; Lazaro C; Kehrer-Sawatzki H
Hum Mutat; 2011 Feb; 32(2):213-9. PubMed ID: 21280148
[TBL] [Abstract][Full Text] [Related]
38. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
[TBL] [Abstract][Full Text] [Related]
39. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients.
Wimmer K; Yao S; Claes K; Kehrer-Sawatzki H; Tinschert S; De Raedt T; Legius E; Callens T; Beiglböck H; Maertens O; Messiaen L
Genes Chromosomes Cancer; 2006 Mar; 45(3):265-76. PubMed ID: 16283621
[TBL] [Abstract][Full Text] [Related]
40. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
